Search Prime Grants

U54CA280868

Cooperative Agreement

Overview

Grant Description
The Medical District UTSW-D First Program - Overall: Abstract

This Dallas Medical District UTSW-D First proposal is submitted jointly by the University of Texas Southwestern Medical Center (UTSW) and the University of Texas at Dallas (UTD). Our institutions have complementary scientific strengths and a track record of productive collaboration.

Our integrated First approach will jointly recruit a cohort of exceptional and diverse junior faculty to the Medical District in the three cluster areas of Biomedical Engineering (BME), Brain Science, and Cancer. Our First programs will catalyze a cultural transformation and increase diversity, equity, inclusion, accessibility (DEIA), and vitality of our faculty.

The overall goal is to improve DEI culture that will enhance recruitment of talents from URGs to become First Scholars, and to nurture them through rigorous career development approaches to help them build their career and retain them in the long run. These achievements in diverse excellence will further increase DEI culture and have long-term impact.

Aim 1 will establish an innovative joint First cohort program using fiscally responsible, evidence-based approaches that will be rigorously tested within our unique environment. We will leverage our experiences from existing institutional cohort development programs such as UTSW's Endowed Scholars (ES) program and UTD's ADVANCE. The longstanding ES program has a 95% promotion rate to Associate Professor with tenure and produced 2 HHMI investigators, dept. chairs, and center directors. UTD's NSF ADVANCE: Organizational Change for Gender Equity in STEM Academic Professions program is newer but has great potential. We will learn from these programs to create our unique joint First program with an explicit focus on cohort hiring for diversity excellence. We will also grow the Science, Technology, Engineering, Mathematics, and Medicine (STEMM) pathways to increase future URG faculty. This aim will focus on recruitment of talented URG faculty and is described in the Administrative Core.

Aim 2 will ensure that our First Scholars thrive and succeed at our institutions for the long-term. We will proactively onboard First Scholars and provide customized mentorship and research support. We will offer executive coaching, management and leadership training, career development, allyship, and sponsorship. These approaches are described in the Faculty Development Core.

Aim 3 will use rigorous evidence-based quantitative and qualitative approaches to evaluate our First program. We will assess the impacts of the cohort model, our interventions, and contextual factors at multiple levels. This aim is described in the Evaluation Core. Our evaluation will inform our future approaches to foster a sustainable institutional culture to increase the diversity of the UTSW and UTD faculty and leadership.

The First legacy will be sustained using data-driven strategies to guide institutional and departmental leaders to incorporate best practices to overcome structural and institutional barriers for DEI culture, and to enhance and deepen the science workforce pathways and academic-community partnerships.
Funding Goals
NOT APPLICABLE
Place of Performance
Texas United States
Geographic Scope
State-Wide
Analysis Notes
Amendment Since initial award the End Date has been shortened from 05/31/28 to 04/08/25 and the total obligations have increased 359% from $498,000 to $2,286,065.
The University Of Texas Southwestern Medical Center was awarded The Medical District UTSW-D FIRST Program Cooperative Agreement U54CA280868 worth $2,286,065 from the National Institute of Allergy and Infectious Diseases in June 2023 with work to be completed primarily in Texas United States. The grant has a duration of 1 year 10 months and was awarded through assistance program 93.310 Trans-NIH Research Support. The Cooperative Agreement was awarded through grant opportunity NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional).

Status
(Complete)

Last Modified 9/5/25

Period of Performance
6/1/23
Start Date
4/8/25
End Date
100% Complete

Funding Split
$2.3M
Federal Obligation
$0.0
Non-Federal Obligation
$2.3M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to U54CA280868

Subgrant Awards

Disclosed subgrants for U54CA280868

Transaction History

Modifications to U54CA280868

Additional Detail

Award ID FAIN
U54CA280868
SAI Number
U54CA280868-2382178221
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Public/State Controlled Institution Of Higher Education
Awarding Office
75NC00 NIH National Cancer Institute
Funding Office
75NA00 NIH OFFICE OF THE DIRECTOR
Awardee UEI
YZJ6DKPM4W63
Awardee CAGE
1CNP4
Performance District
TX-90
Senators
John Cornyn
Ted Cruz

Budget Funding

Federal Account Budget Subfunction Object Class Total Percentage
Office of the Director, National Institutes of Health, Health and Human Services (075-0846) Health research and training Grants, subsidies, and contributions (41.0) $498,000 100%
Modified: 9/5/25